Technical Data
P9007-15E1
Progesterone Receptor (PgR)
Description:
Human PgR exists in two forms: 116kD (B-form) and 81kD (A-form). It acts as ligand activated transcription factor to regulate expression of the target genes. Null mutation in PgR gene leads to pleiotrophic reproductive abnormalities.

Applications:
Suitable for use in ELISA and Immunohistochemistry. Other applications not tested.

Recommended Dilutions:
Immunohistochemistry (Formalin-fixed, paraffin-embedded): 1:50-1:100 for 20 minutes at RT. Staining of formalin-fixed tissues requires boiling tissue sections in 10mM citrate buffer, pH 6.0 for 10-20 minutes followed by cooling at RT for 20 minutes.
Optimal dilutions to be determined by the researcher.

Positive Control:
T47D cells, Breast carcinoma

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGPurified
SizeStorageShippingSourceHost
250ul-20CBlue IceHumanRabbit
Concentration:
~0.2mg/ml
Immunogen:
Recombinant protein encoding human progesterone receptor aa412-526. Cellular Localization: Nuclear. MW of Antigen: 81kD and 116kD.
Purity:
Purified
Form
Supplied as a liquid in PBS, pH 7.6, 0.2% BSA, 15mM sodium azide.
Specificity:
Recognizes human Progesterone Receptor.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.